The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

Thousands of users have now reported experiencing severe anxiety and 'meltdowns' which they believe are linked to using ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

In a continued fundraising effort for its integrated health care center, MarillacHealth launched a public campaign to secure ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

The FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela Fitch ...

NAION is a condition that causes sudden vision loss in one eye due to reduced blood flow to the optic nerve. The damaged ...